Vertex Pharmaceuticals Inc. buy The Goldman Sachs Group, Inc.
Start price
31.01.24
/
50%
€397.35
Target price
31.01.25
€515.17
Performance (%)
-6.53%
Price
26.04.24
€371.40
Summary
This prediction is currently active. With a performance of -6.53%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 31.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.324% | 0.324% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $442.00 to $559.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat